ArticleBiology2024
Targeted Overexpression of
Weirong Xing, Sheila Pourteymoor, Anakha Udayakumar, Yian Chen, Subburaman Mohan
Open access · goldAbstract read
In one paragraphArticle in Biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 98% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
5 authors at 2 institutions in 1 country.
Weirong XingMusculoskeletal Disease Center, Loma Linda VA Healthcare System, Loma Linda, CA 92357, USA.
Sheila PourteymoorMusculoskeletal Disease Center, Loma Linda VA Healthcare System, Loma Linda, CA 92357, USA.
Anakha UdayakumarMusculoskeletal Disease Center, Loma Linda VA Healthcare System, Loma Linda, CA 92357, USA.
Yian ChenMusculoskeletal Disease Center, Loma Linda VA Healthcare System, Loma Linda, CA 92357, USA.
Subburaman MohanMusculoskeletal Disease Center, Loma Linda VA Healthcare System, Loma Linda, CA 92357, USA.ORCID 0000-0003-0063-986X Loma Linda University · USVA Loma Linda Healthcare System · US
Funding
Transgenic Approaches to Evaluate IGF-I Role in Peak BMDR01AR048139 · NIAMS · LOMA LINDA VETERANS ASSN RESEARCH &EDUC · PI MOHAN, SUBBURAMAN · 2003 to 2025
$4.7MRole and Mechanism of Claudin-11 Action and Signaling in BoneR01AR070806 · NIAMS · LOMA LINDA VETERANS ASSN RESEARCH & EDUC · PI MOHAN, SUBBURAMAN · 2017 to 2023
$1.6MThyroid hormone receptor β1 agonist therapy for the treatment of bone marrow adiposity in aging and obesityR21AG062866 · NIA · LOMA LINDA VETERANS ASSN RESEARCH & EDUC · PI MOHAN, SUBBURAMAN · 2020 to 2021
$403kTransgenic Approaches to Evalute IGF-1 Role in Peak BMDR56AR048139 · NIAMS · LOMA LINDA VETERANS ASSN RESEARCH & EDUC · PI MOHAN, SUBBURAMAN · 2008 to 2008
$258kBLRD Research Career Scientist Award ApplicationIK6BX005381 · VA · VA LOMA LINDA HEALTHCARE SYSTEM · PI SUBBURAMAN MOHAN · 2021 to 2026
–BLRD VA IK6 BX005381NIAMS NIH HHS R01 AR048139NIAMS NIH HHS R01 AR070806NIAMS NIH HHS R56 AR048139NIA NIH HHS R21 AG062866NIH HHS R01 AR070806
6 · The paper itselfAbstract
Indexed as
adipocyteadipogenesisbone formationClaudin11differentiationosteoblastsosteogenesisoverexpressionskeletontransgenic
Identifiers
PMID38392326
PMCPMC10886834
OpenAlexW4391681107
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390